{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:58:45Z","timestamp":1790423925582,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-916","type":"journal-article","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T18:18:02Z","timestamp":1417717082000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds"],"prefix":"10.1186","volume":"14","author":[{"given":"Lev","family":"Stimmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Dehay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Nemati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Massonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Richon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Decaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Klijanienko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger","family":"Johannes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,4]]},"reference":[{"issue":"Suppl 3","key":"5084_CR1","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/S0959-8049(11)70145-9","volume":"47","author":"SR Johnston","year":"2011","unstructured":"Johnston SR: The role of chemotherapy and targeted agents in patients with metastatic breast cancer. Eur J Cancer. 2011, 47 (Suppl 3): S38-S47.","journal-title":"Eur J Cancer"},{"issue":"6","key":"5084_CR2","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1159\/000334093","volume":"57","author":"AI Shamseddine","year":"2011","unstructured":"Shamseddine AI, Farhat FS: Platinum-based compounds for the treatment of metastatic breast cancer. Chemotherapy. 2011, 57 (6): 468-487. 10.1159\/000334093.","journal-title":"Chemotherapy"},{"issue":"17","key":"5084_CR3","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.1002\/anie.201104384","volume":"51","author":"ME Ivarsson","year":"2012","unstructured":"Ivarsson ME, Leroux JC, Castagner B: Targeting bacterial toxins. Angew Chem Int Ed Engl. 2012, 51 (17): 4024-4045. 10.1002\/anie.201104384. doi:10.1002\/anie.201104384. Epub 2012 Mar 22","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"5084_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1751-7915.2010.00180.x","volume":"4","author":"N Engedal","year":"2011","unstructured":"Engedal N, Skotland T, Torgersen ML, Sandvig K: Shiga toxin and its use in targeted cancer therapy and imaging. Microb Biotechnol. 2011, 4 (1): 32-46. 10.1111\/j.1751-7915.2010.00180.x.","journal-title":"Microb Biotechnol"},{"issue":"2","key":"5084_CR5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrmicro2279","volume":"8","author":"L Johannes","year":"2010","unstructured":"Johannes L, Romer W: Shiga toxins\u2013from cell biology to biomedical applications. Nat Rev Microbiol. 2010, 8 (2): 105-116.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"5084_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2174\/187152506778520718","volume":"4","author":"S Bekri","year":"2006","unstructured":"Bekri S, Lidove O, Jaussaud R, Knebelmann B, Barbey F: The role of ceramide trihexoside (globotriaosylceramide) in the diagnosis and follow-up of the efficacy of treatment of Fabry disease: a review of the literature. Cardiovasc Hematol Agents Med Chem. 2006, 4 (4): 289-297. 10.2174\/187152506778520718.","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"7170","key":"5084_CR7","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nature05996","volume":"450","author":"W R\u00f6mer","year":"2007","unstructured":"R\u00f6mer W, Berland L, Chambon V, Gaus K, Windschiegl B, Tenza D, Aly MR, Fraisier V, Florent JC, Perrais D, Lamaze C, Raposo G, Steinem C, Sens P, Bassereau P, Johannes L: Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature. 2007, 450 (7170): 670-675. 10.1038\/nature05996.","journal-title":"Nature"},{"issue":"7","key":"5084_CR8","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.cell.2008.12.009","volume":"135","author":"L Johannes","year":"2008","unstructured":"Johannes L, Popoff V: Tracing the retrograde route in protein trafficking. Cell. 2008, 135 (7): 1175-1187. 10.1016\/j.cell.2008.12.009.","journal-title":"Cell"},{"issue":"23","key":"5084_CR9","first-page":"5309","volume":"56","author":"S Hakomori","year":"1996","unstructured":"Hakomori S: Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 1996, 56 (23): 5309-5318.","journal-title":"Cancer Res"},{"key":"5084_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1471-2407-9-67","volume":"9","author":"D Johansson","year":"2009","unstructured":"Johansson D, Kosovac E, Moharer J, Ljuslinder I, Brannstrom T, Johansson A, Behnam-Motlagh P: Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis. BMC Cancer. 2009, 9: 67-10.1186\/1471-2407-9-67.","journal-title":"BMC Cancer"},{"issue":"4","key":"5084_CR11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1525-1438.2007.01090.x","volume":"18","author":"F Wei","year":"2008","unstructured":"Wei F, Cao S, Ren X, Liu H, Yu J, Li H, Hao X: Efficient antiproliferative and antiangiogenic effects on human ovarian cancer growth by gene transfer of attenuated mutants of Shiga-like toxin I. Int J Gynecol Cancer. 2008, 18 (4): 677-691. 10.1111\/j.1525-1438.2007.01090.x.","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"5084_CR12","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1158\/1535-7163.MCT-11-0006","volume":"10","author":"M Maak","year":"2011","unstructured":"Maak M, Nitsche U, Keller L, Wolf P, Sarr M, Thiebaud M, Rosenberg R, Langer R, Kleeff J, Friess H, Johannes L, Janssen KP: Tumor-specific targeting of pancreatic cancer with Shiga toxin B-subunit. Mol Cancer Ther. 2011, 10 (10): 1918-1928. 10.1158\/1535-7163.MCT-11-0006.","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"5084_CR13","doi-asserted-by":"publisher","first-page":"e6813","DOI":"10.1371\/journal.pone.0006813","volume":"4","author":"U Distler","year":"2009","unstructured":"Distler U, Souady J, Hulsewig M, Drmic-Hofman I, Haier J, Friedrich AW, Karch H, Senninger N, Dreisewerd K, Berkenkamp S, Schmidt MA, Peter-Katalini\u0107 J, M\u00fcthing J: Shiga toxin receptor Gb3Cer\/CD77: tumor-association and promising therapeutic target in pancreas and colon cancer. PLoS One. 2009, 4 (8): e6813-10.1371\/journal.pone.0006813.","journal-title":"PLoS One"},{"issue":"8","key":"5084_CR14","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1158\/1535-7163.MCT-08-0430","volume":"7","author":"T Falguieres","year":"2008","unstructured":"Falguieres T, Maak M, von Weyhern C, Sarr M, Sastre X, Poupon MF, Robine S, Johannes L, Janssen KP: Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen-based delivery tool. Mol Cancer Ther. 2008, 7 (8): 2498-2508. 10.1158\/1535-7163.MCT-08-0430.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"5084_CR15","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/sj.neo.7900243","volume":"4","author":"B Salhia","year":"2002","unstructured":"Salhia B, Rutka JT, Lingwood C, Nutikka A, Van Furth WR: The treatment of malignant meningioma with verotoxin. Neoplasia. 2002, 4 (4): 304-311. 10.1038\/sj.neo.7900243.","journal-title":"Neoplasia"},{"issue":"1","key":"5084_CR16","first-page":"33","volume":"11","author":"S Arab","year":"1999","unstructured":"Arab S, Rutka J, Lingwood C: Verotoxin induces apoptosis and the complete, rapid, long-term elimination of human astrocytoma xenografts in nude mice. Oncol Res. 1999, 11 (1): 33-39.","journal-title":"Oncol Res"},{"issue":"2","key":"5084_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1023\/B:AGEN.0000011799.47529.fd","volume":"6","author":"HM Heath-Engel","year":"2003","unstructured":"Heath-Engel HM, Lingwood CA: Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker. Angiogenesis. 2003, 6 (2): 129-141.","journal-title":"Angiogenesis"},{"issue":"3","key":"5084_CR18","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1097\/01.ju.0000100110.11129.85","volume":"171","author":"S Ishitoya","year":"2004","unstructured":"Ishitoya S, Kurazono H, Nishiyama H, Nakamura E, Kamoto T, Habuchi T, Terai A, Ogawa O, Yamamoto S: Verotoxin induces rapid elimination of human renal tumor xenografts in SCID mice. J Urol. 2004, 171 (3): 1309-1313. 10.1097\/01.ju.0000100110.11129.85.","journal-title":"J Urol"},{"issue":"8","key":"5084_CR19","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ, Panel M: Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011, 22 (8): 1736-1747. 10.1093\/annonc\/mdr304.","journal-title":"Ann Oncol"},{"issue":"1","key":"5084_CR20","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1186\/bcr3095","volume":"14","author":"F Reyal","year":"2012","unstructured":"Reyal F, Guyader C, Decraene C, Lucchesi C, Auger N, Assayag F, De Plater L, Gentien D, Poupon MF, Cottu P, De Cremoux P, Gestraud P, Vincent-Salomon A, Fontaine JJ, Roman-Roman S, Delattre O, Decaudin D, Marangoni E: Molecular profiling of patient-derived breast cancer xenografts. Breast Cancer Res. 2012, 14 (1): R11-10.1186\/bcr3095.","journal-title":"Breast Cancer Res"},{"key":"5084_CR21","first-page":"209","volume":"73","author":"F Mallard","year":"2003","unstructured":"Mallard F, Johannes L: Shiga toxin B-subunit as a tool to study retrograde transport. Methods Mol Med. 2003, 73: 209-220.","journal-title":"Methods Mol Med"},{"issue":"8","key":"5084_CR22","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1091\/mbc.12.8.2453","volume":"12","author":"T Falguieres","year":"2001","unstructured":"Falguieres T, Mallard F, Baron C, Hanau D, Lingwood C, Goud B, Salamero J, Johannes L: Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol Biol Cell. 2001, 12 (8): 2453-2468. 10.1091\/mbc.12.8.2453.","journal-title":"Mol Biol Cell"},{"issue":"5","key":"5084_CR23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/labinvest.2013.44","volume":"93","author":"V Petit","year":"2013","unstructured":"Petit V, Massonnet G, Maciorowski Z, Touhami J, Thuleau A, Nemati F, Laval J, Chateau-Joubert S, Servely JL, Vallerand D, Fontaine JJ, Taylor N, Battini JL, Sitbon M, Decaudin D: Optimization of tumor xenograft dissociation for the profiling of cell surface markers and nutrient transporters. Lab Invest. 2013, 93 (5): 611-621. 10.1038\/labinvest.2013.44. doi:10.1038\/labinvest.2013.44. Epub 2013 Mar 4","journal-title":"Lab Invest"},{"issue":"1","key":"5084_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/0971-5851.96964","volume":"33","author":"AR Wilkinson","year":"2012","unstructured":"Wilkinson AR, Mahore SD, Maimoon SA: FNAC in the diagnosis of lymph node malignancies: a simple and sensitive tool. Indian J Med Paediatr Oncol. 2012, 33 (1): 21-24. 10.4103\/0971-5851.96964.","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"5","key":"5084_CR25","first-page":"1557","volume":"29","author":"RJ Broom","year":"2009","unstructured":"Broom RJ, Tang PA, Simmons C, Bordeleau L, Mulligan AM, O'Malley FP, Miller N, Andrulis IL, Brenner DM, Clemons MJ: Changes in estrogen receptor, progesterone receptor and Her-2\/neu status with time: discordance rates between primary and metastatic breast cancer. Anticancer Res. 2009, 29 (5): 1557-1562.","journal-title":"Anticancer Res"},{"issue":"8","key":"5084_CR26","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/sj.bjc.6605900","volume":"103","author":"L de Plater","year":"2012","unstructured":"de Plater L, Lauge A, Guyader C, Poupon MF, Assayag F, de Cremoux P, Vincent-Salomon A, Stoppa-Lyonnet D, Sigal-Zafrani B, Fontaine JJ, Brough R, Lord CJ, Ashworth A, Cottu P, Decaudin D, Marangoni E: Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation. Br J Cancer. 2012, 103 (8): 1192-1200.","journal-title":"Br J Cancer"},{"issue":"13","key":"5084_CR27","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1158\/1078-0432.CCR-07-0078","volume":"13","author":"E Marangoni","year":"2007","unstructured":"Marangoni E, Vincent-Salomon A, Auger N, Degeorges A, Assayag F, de Cremoux P, de Plater L, Guyader C, De Pinieux G, Judde JG, Rebucci M, Tran-Perennou C, Sastre-Garau X, Sigal-Zafrani B, Delattre O, Di\u00e9ras V, Poupon MF: A new model of patient tumor-derived breast cancer xenografts for preclinical assays. Clin Cancer Res. 2007, 13 (13): 3989-3998. 10.1158\/1078-0432.CCR-07-0078.","journal-title":"Clin Cancer Res"},{"issue":"Suppl 1","key":"5084_CR28","doi-asserted-by":"publisher","first-page":"S675","DOI":"10.1007\/s12032-010-9732-8","volume":"28","author":"D Devenica","year":"2011","unstructured":"Devenica D, Cikes Culic V, Vuica A, Markotic A: Biochemical, pathological and oncological relevance of Gb3Cer receptor. Med Oncol. 2011, 28 (Suppl 1): S675-S684.","journal-title":"Med Oncol"},{"issue":"10","key":"5084_CR29","first-page":"553","volume":"9","author":"S Arab","year":"1997","unstructured":"Arab S, Russel E, Chapman WB, Rosen B, Lingwood CA: Expression of the verotoxin receptor glycolipid, globotriaosylceramide, in ovarian hyperplasias. Oncol Res. 1997, 9 (10): 553-563.","journal-title":"Oncol Res"},{"issue":"6","key":"5084_CR30","first-page":"133","volume":"44","author":"S Pervez","year":"1994","unstructured":"Pervez S, Shaikh H, Aijaz F, Aziz SA, Naqvi M, Hasan SH: Immunohistochemical estrogen receptor determination in human breast carcinoma: correlation with histologic differentiation and age of the patients. J Pak Med Assoc. 1994, 44 (6): 133-136.","journal-title":"J Pak Med Assoc"},{"issue":"2","key":"5084_CR31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.molonc.2009.12.001","volume":"4","author":"IO Potapenko","year":"2010","unstructured":"Potapenko IO, Haakensen VD, Luders T, Helland A, Bukholm I, Sorlie T, Kristensen VN, Lingjaerde OC, Borresen-Dale AL: Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression. Mol Oncol. 2010, 4 (2): 98-118. 10.1016\/j.molonc.2009.12.001.","journal-title":"Mol Oncol"},{"issue":"13","key":"5084_CR32","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1073\/pnas.1302825110","volume":"110","author":"YJ Liang","year":"2013","unstructured":"Liang YJ, Ding Y, Levery SB, Lobaton M, Handa K, Hakomori SI: Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells. Proc Natl Acad Sci U S A. 2013, 110 (13): 4968-4973. 10.1073\/pnas.1302825110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"5084_CR33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.critrevonc.2012.05.002","volume":"84","author":"S Vignot","year":"2012","unstructured":"Vignot S, Besse B, Andre F, Spano JP, Soria JC: Discrepancies between primary tumor and metastasis: a literature review on clinically established biomarkers. Crit Rev Oncol Hematol. 2012, 84 (3): 301-313. 10.1016\/j.critrevonc.2012.05.002. doi:10.1016\/j.critrevonc.2012.05.002. Epub 2012 Jun 17","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"5084_CR34","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1200\/JCO.2010.33.8889","volume":"30","author":"N Niikura","year":"2012","unstructured":"Niikura N, Liu J, Hayashi N, Mittendorf EA, Gong Y, Palla SL, Tokuda Y, Gonzalez-Angulo AM, Hortobagyi GN, Ueno NT: Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors. J Clin Oncol. 2012, 30 (6): 593-599. 10.1200\/JCO.2010.33.8889.","journal-title":"J Clin Oncol"},{"issue":"3","key":"5084_CR35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/mas.20253","volume":"29","author":"J Muthing","year":"2010","unstructured":"Muthing J, Distler U: Advances on the compositional analysis of glycosphingolipids combining thin-layer chromatography with mass spectrometry. Mass Spectrom Rev. 2010, 29 (3): 425-479.","journal-title":"Mass Spectrom Rev"},{"issue":"2","key":"5084_CR36","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/sj.bjc.6605467","volume":"102","author":"D Johansson","year":"2010","unstructured":"Johansson D, Andersson C, Moharer J, Johansson A, Behnam-Motlagh P: Cisplatin-induced expression of Gb3 enables verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cells. Br J Cancer. 2010, 102 (2): 383-391. 10.1038\/sj.bjc.6605467.","journal-title":"Br J Cancer"},{"issue":"5","key":"5084_CR37","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00280-012-1841-y","volume":"69","author":"C Lin","year":"2012","unstructured":"Lin C, Chen DR, Chang KJ, Chang TW, Wang HC: A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin and trastuzumab for T2 breast cancers. Cancer Chemother Pharmacol. 2012, 69 (5): 1363-1368. 10.1007\/s00280-012-1841-y. doi:10.1007\/s00280-012-1841-y. Epub 2012 Feb 19","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"5084_CR38","first-page":"573","volume":"2","author":"S Kasibhatla","year":"2003","unstructured":"Kasibhatla S, Tseng B: Why target apoptosis in cancer treatment?. Mol Cancer Ther. 2003, 2 (6): 573-580.","journal-title":"Mol Cancer Ther"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-916.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-916\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-916.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T07:13:05Z","timestamp":1630566785000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["5084"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-916","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"26 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"916"}}